Уноси

• Cardioprotective Effects of Ursodeoxycholic Acid in Isoprenaline-Induced Myocardial Injury in Rats (2024-09)

  D. Mihajlović, Ђ. Ђукановић, M. Gajić Bojić, S. Jovičić, Н. Мандић-Ковачевић, С. Улетиловић, Ž. Maksimović, N. Pavlović, B. Dojčinović, S. Bolevich, M. Mikov, Р. Шкрбић, N. Banjac, V. Vasović, Cardioprotective Effects of Ursodeoxycholic Acid in Isoprenaline-Induced Myocardial Injury in Rats, Biomolecules, Sep, 2024

• The potential cardioprotective effect of bile acids in isoprenaline-induced myocardial injury (2023-07)

  Đ. Đukanović, D. Mihajlović, Ž. Maksimović, S. Uletilović, N. Mandić-Kovačević, Т. Cvjetković, U. Maličević, М. Gajić Bojić, N. Vesić, Т. Мilivojac, А. Кrivokuća, M. Mikov, R. Škrbić, The potential cardioprotective effect of bile acids in isoprenaline-induced myocardial injury, Jul, 2023

• Ursodeoxycholic and chenodeoxycholic bile acids attenuate systemic and liver inflammation induced by lipopolysaccharide in rats (2024-05)

  T. Milivojac, M. Grabež, A. Krivokuća, U. Maličević, M. Gajić Bojić, Đ. Đukanović, S. Uletilović, N. Mandić-Kovačević, T. Cvjetković, M. Barudžija, N. Vojinović, A. Šmitran, LJ. Amidžić, M. Stojiljković, M. Čolić, M. Mikov, R. Škrbić, Ursodeoxycholic and chenodeoxycholic bile acids attenuate systemic and liver inflammation induced by lipopolysaccharide in rats, MOLECULAR AND CELLULAR BIOCHEMISTRY, May, 2024

• Registar lijekova Republike Srpske (2002)

  R. Škrbić, V. Marković Peković, S. Stoisavljević-Šatara, M. Mikov, M. Stanulović, Registar lijekova Republike Srpske, Medicinski fakultet Banja Luka, 2002

• The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries (2019)

  T. Kovačević, B. Miljkovic, M. Mikov, S. Stojisavljević-Šatara, S. Dragic, D. Momcicevic, P. Kovačević, The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries, DOSE-RESPONSE, pp. 0 - 0, 2019

• The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries (2019-05)

  T. Kovačević, B. Miljkovic, M. Mikov, S. Stoisavljević-Šatara, S. Dragić, D. Momčičević, P. Kovačević, The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries, DOSE-RESPONSE, Vol. 17, No. 2, pp. 1 - 6, May, 2019

• Challenges in authorization and administration of biological drugs and biosimilars in Bosnia and Herzegovina (2019-09)

  B. Tubić, S. Kecman, R. Škrbić, L. Nježić, N. Stojaković, S. Goločorbin Kon, M. Mikov, Challenges in authorization and administration of biological drugs and biosimilars in Bosnia and Herzegovina, ABSTRACT BOOK, pp. 95 - 96, Sep, 2019

• DRUG MARKET IN BOSNIA AND HERZEGOVINA – TO WHAT EXTENT THE PHARMACEUTICAL INDUSTRY IS IN LINE WITH THE POPULATION’S NEEDS (2019-09)

  S. Kecman, B. Tubić, R. Škrbić, N. Stojaković, L. Nježić, S. Goločorbin Kon, M. Mikov, DRUG MARKET IN BOSNIA AND HERZEGOVINA – TO WHAT EXTENT THE PHARMACEUTICAL INDUSTRY IS IN LINE WITH THE POPULATION’S NEEDS, ABSTRACT BOOK, pp. 265 - 266, Sep, 2019

• The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach (2021-01)

  V. Topić Vučenović, Z. Rajkovača, D. Jelić, D. Stanimirović, M. Mikov, B. Miljković, K. Vučićević, The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach, https://www.paganz.org/abstracts/the-influence-of-biologically-effective-dose-bed-on-the-131i-therapy-response-in-patients-with-benign-thyroid-disease-nonlinear-mixed-effect-modelling-approach/, Jan, 2021

• UTICAJ PROBIOTIKA NA METABOLIZAM SULFASALAZINA U OBOLJELIH OD INFLAMATORNE BOLESTI CRIJEVA (2017)

• Population exposure-response model of 131I in patients with benign thyroid disease (2021-10)

  V. Topić Vučenović, Z. Rajkovača, D. Jelić, D. Stanimirović, M. Mikov, B. Miljković, K. Vučićević, Population exposure-response model of 131I in patients with benign thyroid disease, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol. 165, pp. 105942 - 105942, Oct, 2021

• Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind, Placebo-Controlled Clinical Study (2024-02)

  Б. Лакић, Р. Шкрбић, С. Улетиловић, N. Mandić-Kovačević, М. Грабеж, М. Поповић Шарић, М. Стојиљковић, И. Солдатовић, З. Јањетовић, А. Стокановић, Н. Стојаковић, М. Миков, Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind, Placebo-Controlled Clinical Study, Journal of Diabetes Research, Vol. 2024, Feb, 2024

• Основе фармакокинетике са биофармацијом (2014)

  М. Миков, С. Голочорбин Кон, Д. Бокоњић, В. Драгојевић-Симић, Е. Шаркиновић, А. Ковачевић, С. Гигов, В. Топић, Н. Ранчић, Основе фармакокинетике са биофармацијом, Ortomedics book, Novi Sad, 2014

• Influence of Bile Acids on Rat Gut Microflora Deterioration Induced by Oral Ampicillin Treatment (2015-06)

  Lj. Suvajdžić, N. Stojaković, М. Мikov, S. Stoisavljević-Šatara, R. Škrbić, Influence of Bile Acids on Rat Gut Microflora Deterioration Induced by Oral Ampicillin Treatment, Acta Scientiae Veterinariae, Vol. 43, pp. 1282 - 1286, Jun, 2015

• Probiotic Treatment does not Change Sulphasalazine and its Metabolites Excretion in Patients with Inflammatory Bowel Disease (2020-07)

  N. Stojaković, М. Мiкоv, S.Trbojević, R. Škrbić, S. Stoisavljević Šatara, Probiotic Treatment does not Change Sulphasalazine and its Metabolites Excretion in Patients with Inflammatory Bowel Disease, Journal of Probiotics & Health, Vol. 8, No. 3, pp. 1 - 9, Jul, 2020